Picture of Bioquest logo

BQST Bioquest Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual income statement for Bioquest, fiscal year end - April 30th, USD millions except per share, conversion factor applied.

2013
April 30th
2014
April 30th
2021
April 30th
2022
April 30th
Period Length:12 M12 M12 M12 M
Source:10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
Status:FinalFinalFinalFinal
Revenue
Total Revenue0000
Cost of Revenue
Gross Profit-1.41
Selling / General / Administrative Expenses
Total Operating Expenses0.0080.1242.20.818
Operating Profit-0.008-0.124-2.2-0.818
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-0.008-0.488-2.32-0.821
Provision for Income Taxes
Net Income After Taxes-0.008-0.488-2.32-0.821
Net Income Before Extraordinary Items
Net Income-0.008-0.488-2.32-0.821
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income-0.008-0.488-2.32-0.821
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.032-1.8-0.281-0.081
Dividends per Share

Or unlock with your email

Or unlock with your email